Indraprastha Medical Corporation Limited
300.25
INR
-5.60
(-1.83%)
ISIN
INE681B01017
Return %
Stock
S&P 500
1Y
-45.34
14.20
3Y
90.63
81.12
5Y
303.02
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Shivakumar Pattabhiraman
- Full Time Employees
- 3,000
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Sarita Vihar New Delhi DE India 110076
- IPO Date
- Feb 24, 1997
- Website
- apollohospitals.com
- Similar Companies
- Business
- Indraprastha Medical Corporation Limited operates as a healthcare services provider managing super specialty hospitals including Indraprastha Apollo Hospitals. The company offers a broad range of medical services spanning approximately 52 specialties such as cardiology, orthopaedics, gynaecology, paediatrics, spine surgery, urology, and vascular endovascular surgery. Its services encompass emergency care, outpatient and inpatient treatments, advanced diagnostics including X-rays, MRI, CT scans, laboratory testing, and health check-up packages. The firm also provides telemedicine services for remote consultation. Beyond healthcare services, Indraprastha Medical Corporation develops and supplies medical devices and equipment, such as surgical instruments, patient monitoring systems, and hospital infrastructure solutions including modular operating rooms and ICUs. Its pharmaceutical division manufactures over-the-counter medicines, prescription drugs, and healthcare consumables like surgical gloves, syringes, and bandages. The company invests in research and development for innovation in medical technology and offers healthcare consulting services including strategic planning and operational improvement for medical facilities. Indraprastha Medical Corporation operates primarily in India with facilities in the National Capital Region, notably a 718-bed hospital in Sarita Vihar, New Delhi, and a 46-bed hospital in Noida. Founded in 1996 as a joint venture between Apollo Hospitals and the Delhi government, it is headquartered in New Delhi. Recent developments in the last 1-2 years include the continued expansion of healthcare services with updated unaudited financial results for 2025 indicating growth in net sales and profitability. The company participated in key investor and analyst conferences in 2025 and declared a dividend for the fiscal year 2024-2025, reflecting financial stability. It maintains a strategic presence in the NCR with ongoing investments supporting infrastructure and service enhancement. The company remains nearly debt-free with a rising profit trajectory, focusing on strengthening its position in advanced medical treatments and expanding telemedicine capabilities. There have been no recent name changes or major reorganizations, but it emphasizes continuous innovation and service diversification to address evolving healthcare needs in India. The company is listed on the National Stock Exchange of India under ticker INDRAMEDCO.NS. Market activity and financial disclosures through 2025 show steady operational performance and commitment to delivering comprehensive healthcare solutions across medical specialties.